Top Markets
Coin of the day
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
Peringkat dalam Saham #30260
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Harga Saham
$1.88
Terakhir disinkronkan: 2026-08-18
Kapitalisasi Pasar
$17.59M
Perubahan (1 hari)
0.81%
Perubahan (1 tahun)
-92.40%
Negara
US
Perdagangan Tvardi Therapeutics, Inc. (TVRD)

Kategori

Riwayat pemecahan saham untuk Tvardi Therapeutics, Inc. (TVRD)
Saham Tvardi Therapeutics, Inc. (simbol: TVRD) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 19, 2026.
Satu lembar saham TVRD yang dibeli sebelum Aug 19, 2026 sekarang setara dengan 0 lembar saham TVRD.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR